Felix Hofer

563 total citations
39 papers, 347 citations indexed

About

Felix Hofer is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Felix Hofer has authored 39 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Felix Hofer's work include Atrial Fibrillation Management and Outcomes (10 papers), Heart Failure Treatment and Management (9 papers) and Acute Myocardial Infarction Research (7 papers). Felix Hofer is often cited by papers focused on Atrial Fibrillation Management and Outcomes (10 papers), Heart Failure Treatment and Management (9 papers) and Acute Myocardial Infarction Research (7 papers). Felix Hofer collaborates with scholars based in Austria, Poland and United States. Felix Hofer's co-authors include Christian Hengstenberg, Hans Wägner, Christian Baumgärtner, Andreas Hirt, S Barandun, Paul Imbach, Max‐Paul Winter, Alexander Niessner, Iréne Lang and Patrick Sulzgruber and has published in prestigious journals such as Scientific Reports, European Heart Journal and Thrombosis and Haemostasis.

In The Last Decade

Felix Hofer

31 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Felix Hofer Austria 9 165 85 84 73 59 39 347
César Jiménez Spain 8 53 0.3× 48 0.6× 32 0.4× 37 0.5× 43 0.7× 25 368
Seyed Mohammad Sadegh Pezeshki Iran 8 56 0.3× 48 0.6× 49 0.6× 52 0.7× 47 0.8× 22 273
Sham Singh South Africa 7 38 0.2× 84 1.0× 56 0.7× 41 0.6× 41 0.7× 8 328
Oshrat E Tayer-Shifman Israel 12 26 0.2× 78 0.9× 39 0.5× 40 0.5× 54 0.9× 31 335
Nicholas Adamstein United States 5 90 0.5× 118 1.4× 72 0.9× 10 0.1× 44 0.7× 6 323
Radhika Gangaraju United States 10 55 0.3× 99 1.2× 42 0.5× 120 1.6× 36 0.6× 44 379
Cemal Beş Türkiye 11 31 0.2× 99 1.2× 78 0.9× 67 0.9× 72 1.2× 68 464
Emile L.E. de Bruijne Netherlands 10 110 0.7× 80 0.9× 77 0.9× 202 2.8× 29 0.5× 13 417
Vyron Markussis Greece 10 234 1.4× 14 0.2× 64 0.8× 155 2.1× 53 0.9× 15 497

Countries citing papers authored by Felix Hofer

Since Specialization
Citations

This map shows the geographic impact of Felix Hofer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix Hofer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix Hofer more than expected).

Fields of papers citing papers by Felix Hofer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felix Hofer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix Hofer. The network helps show where Felix Hofer may publish in the future.

Co-authorship network of co-authors of Felix Hofer

This figure shows the co-authorship network connecting the top 25 collaborators of Felix Hofer. A scholar is included among the top collaborators of Felix Hofer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felix Hofer. Felix Hofer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hammer, Andreas, Felix Hofer, Lorenz Koller, et al.. (2025). Mid-Regional Pro-Adrenomedullin Is Associated with Adverse Cardiovascular Outcomes After Cardiac Surgery. Journal of Personalized Medicine. 15(2). 47–47.
2.
Hammer, Andreas, Felix Hofer, Max Lenz, et al.. (2025). Beyond obesity: metabolic status as a key driver for cardiovascular outcomes in patients undergoing invasive coronary angiography. European Heart Journal - Quality of Care and Clinical Outcomes. 11(6). 825–834.
3.
Hammer, Andreas, Felix Hofer, Bernhard Frey, et al.. (2025). Drug-coated balloon vs drug-eluting stent in de novo coronary lesions: a propensity score matched cohort study. Clinical Research in Cardiology. 115(1). 60–68.
4.
Hammer, Andreas, Lorenz Koller, René Rettl, et al.. (2025). The Prognostic Interplay of Heart Failure and Chronic Kidney Disease in Atrial Fibrillation: Focus on Cardiorenal Outcomes. Cardiorenal Medicine. 15(1). 607–618.
5.
Rettl, René, Raffaella Calabretta, Franz Duca, et al.. (2024). DPD Quantification Correlates With Extracellular Volume and Disease Severity in Wild-Type Transthyretin Cardiac Amyloidosis. JACC Advances. 3(10). 101261–101261. 3 indexed citations
6.
Koller, Lorenz, Felix Hofer, Andreas Hammer, et al.. (2023). Soluble urokinase plasminogen activator receptor and survival in elective cardiac surgery. European Journal of Clinical Investigation. 53(5). e13953–e13953. 1 indexed citations
7.
Hammer, Andreas, Felix Hofer, Lorenz Koller, et al.. (2023). Sex-Related Disparities in Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes and Heart Failure. Journal of Women s Health. 32(11). 1219–1228. 4 indexed citations
8.
Hammer, Andreas, Mario Krammel, Sebastian Schnaubelt, et al.. (2023). The Impact of Preclinical High Potent P2Y12 Inhibitors on Decision Making at Discharge and Clinical Outcomes in Patients with Acute Coronary Syndrome. Journal of Clinical Medicine. 12(12). 4094–4094. 1 indexed citations
9.
Koller, Lorenz, Alexandra Hammer, Felix Hofer, et al.. (2023). Routinely available inflammation biomarkers as predictors of adverse outcomes following coronary angiography. European Heart Journal. 44(Supplement_2). 1 indexed citations
10.
Hofer, Felix, Andreas Hammer, Lorenz Koller, et al.. (2023). Prescribing trends of sodium-glucose cotransporter 2 Inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fraction. European Heart Journal. 44(Supplement_2).
11.
Nitsche, Christian, Raffaella Calabretta, Matthias Koschutnik, et al.. (2022). Prevalence and Outcomes of Cardiac Amyloidosis in All-Comer Referrals for Bone Scintigraphy. Journal of Nuclear Medicine. 63(12). 1906–1911. 13 indexed citations
12.
Hofer, Felix, Patrick Sulzgruber, Christian Gerges, et al.. (2022). Relationship of Diabetes, Heart Failure, and N-Terminal Pro-B-Type Natriuretic Peptide with Cardiovascular Outcomes in Patients with Atrial Fibrillation. ESC Heart Failure. 9(4). 2367–2377. 3 indexed citations
13.
Richter, Bernhard, Lorenz Koller, Felix Hofer, et al.. (2022). Galectin-3 is an independent predictor of postoperative atrial fibrillation and survival after elective cardiac surgery. Heart Rhythm. 19(11). 1774–1780. 8 indexed citations
14.
Hofer, Felix, Bernhard Richter, Patrick Sulzgruber, et al.. (2021). Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart Failure. Cardiovascular Drugs and Therapy. 36(3). 497–504. 9 indexed citations
15.
Hammer, Andreas, Felix Hofer, Lorenz Koller, et al.. (2021). The Prognostic Impact of Anti-thrombotic Treatment Strategies After Biological Aortic Valve Replacement. Cardiovascular Drugs and Therapy. 36(6). 1137–1145.
16.
Schnaubelt, Sebastian, Lorenz Koller, Felix Hofer, et al.. (2021). The impact of invasive respiratory support on the development of postoperative atrial fibrillation following cardiac surgery. Journal of Clinical Anesthesia. 72. 110309–110309. 1 indexed citations
17.
Hofer, Felix, Andreas Hammer, Lorenz Koller, et al.. (2021). Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Coronary Artery Disease. Cardiovascular Drugs and Therapy. 35(6). 1161–1170. 6 indexed citations
18.
Sulzgruber, Patrick, Mario Krammel, Klaus Herbich, et al.. (2020). An Increase in Acute Heart Failure Offsets the Reduction in Acute Coronary Syndrome During Coronavirus Disease 2019 (COVID-19) Outbreak. ESC Heart Failure. 8(1). 782–783. 2 indexed citations
19.
Winter, Max‐Paul, Philipp E. Bartko, Felix Hofer, et al.. (2020). Evolution of outcome and complications in TAVR: a meta-analysis of observational and randomized studies. Scientific Reports. 10(1). 15568–15568. 62 indexed citations
20.
Hofer, Felix, Christian Hengstenberg, Georg Goliasch, et al.. (2019). Transcatheter versus surgical aortic valve replacement in low-risk patients: a meta-analysis of randomized trials. Clinical Research in Cardiology. 109(6). 761–775. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026